Literature DB >> 21886469

Operative surgery for enterocutaneous fistula.

Howard Ross1.   

Abstract

The management of the patient with an enterocutaneous fistula is complex and requires coordinated care on many fronts for successful elimination. With optimal nonoperative management a fistula may heal spontaneously, the majority within the first 4 weeks after development. Definitive surgical treatment is best achieved with resection of the bowel containing the fistula and anastomosis of healthy normal bowel. The timing of definitive surgery appears to be optimal months after development, if tolerated. Death rates are low after surgery and patients who experience the recurrence of a fistula after initial attempt at closure can ultimately still be cured.

Entities:  

Keywords:  Enterocutaneous fistulas; operative management; resection; timing

Year:  2010        PMID: 21886469      PMCID: PMC2967319          DOI: 10.1055/s-0030-1262987

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  9 in total

1.  External fistulas arising from the gastro-intestinal tract.

Authors:  L H EDMUNDS; G M WILLIAMS; C E WELCH
Journal:  Ann Surg       Date:  1960-09       Impact factor: 12.969

2.  The pathophysiology of enterocutaneous fistulas.

Authors:  J E Fischer
Journal:  World J Surg       Date:  1983-07       Impact factor: 3.352

3.  Operative strategy in the treatment of enterocutaneous fistulas.

Authors:  G L Hill
Journal:  World J Surg       Date:  1983-07       Impact factor: 3.352

4.  Management of external gastrointestinal fistulas.

Authors:  H A Reber; C Roberts; L W Way; J E Dunphy
Journal:  Ann Surg       Date:  1978-10       Impact factor: 12.969

5.  An 11-year experience of enterocutaneous fistula.

Authors:  P Hollington; J Mawdsley; W Lim; S M Gabe; A Forbes; A J Windsor
Journal:  Br J Surg       Date:  2004-12       Impact factor: 6.939

6.  Review of 404 patients with gastrointestinal fistulas. Impact of parenteral nutrition.

Authors:  P B Soeters; A M Ebeid; J E Fischer
Journal:  Ann Surg       Date:  1979-08       Impact factor: 12.969

7.  Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery.

Authors:  A Craig Lynch; Conor P Delaney; Anthony J Senagore; Jason T Connor; Feza H Remzi; Victor W Fazio
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

8.  The management of enterocutaneous fistula in a regional unit in the United kingdom: a prospective study.

Authors:  Vivek Datta; Alec Engledow; Shirley Chan; Alastair Forbes; C Richard Cohen; Alastair Windsor
Journal:  Dis Colon Rectum       Date:  2010-02       Impact factor: 4.585

9.  Systematic management of postoperative enterocutaneous fistulas: factors related to outcomes.

Authors:  Jose L Martinez; Enrique Luque-de-Leon; Juan Mier; Roberto Blanco-Benavides; Felipe Robledo
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

  9 in total
  4 in total

1.  Surgery for post-operative entero-cutaneous fistulas: is bowel resection plus primary anastomosis without stoma a safe option to avoid early recurrence? Report on 20 cases by a single center and systematic review of the literature.

Authors:  A Lauro; R Cirocchi; N Cautero; A Dazzi; D Pironi; F M Di Matteo; A Santoro; S Faenza; L Pironi; A D Pinna
Journal:  G Chir       Date:  2017 Jul-Aug

Review 2.  Management of Enterocutaneous Fistula: A Review.

Authors:  Pradeep Ghimire
Journal:  JNMA J Nepal Med Assoc       Date:  2022-01-15       Impact factor: 0.556

3.  Enterocutaneous Fistula: Different Surgical Intervention Techniques for Closure along with Comparative Evaluation of Aluminum Paint, Karaya Gum (Hollister) and Gum Acacia for Peristomal Skin Care.

Authors:  Piyush Kumar; Shabi Ahmad
Journal:  J Clin Diagn Res       Date:  2015-12-01

4.  Computed tomography-guided additive manufacturing of Personalized Absorbable Gastrointestinal Stents for intestinal fistulae and perforations.

Authors:  Parinaz Fathi; Gweneviere Capron; Indu Tripathi; Santosh Misra; Fatemeh Ostadhossein; Laura Selmic; Blair Rowitz; Dipanjan Pan
Journal:  Biomaterials       Date:  2019-10-18       Impact factor: 12.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.